Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression

Laboratory Investigation

Volumn 94, Issue 1, 2014, Pages 52-62

  Wei, Qing ^a   Mu, Kun ^a   Li, Tao ^b   Zhang, Ying ^a   Yang, Zhaowen ^a,b   Jia, Xiaoqing ^c   Zhao, Wei ^a   Huai, Wanwan ^a   Guo, Pengbo ^a   Han, Lihui ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

carcinogenesis; hepatocellular carcinoma; inflammasome; NLRP3; parenchymal cell

Indexed keywords

CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME;

ADULT; ARTICLE; CANCER GROWTH; CANCER STAGING; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN DEREGULATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION;

CARRIER PROTEINS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; HEPATOCYTES; HISTOCYTOCHEMISTRY; HUMANS; INFLAMMASOMES; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; TISSUE ARRAY ANALYSIS;

EID: 84891500326     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2013.126     Document Type: Article

References (26)

1. Church LD, Cook GP, McDermott MF. Primer: Inflammasomes and interleukin 1beta in inflammatory disorders. Nat Clin Pract Rheumatol 2008;4:34-42
2. Strowig T, Henao-Mejia J, Elinav E, et al. Inflammasomes in health and disease. Nature 2012;481:278-286
3. Martinon F, Mayor A, Tschopp J. The inflammasomes: Guardians of the body. Annu Rev Immunol 2009;27:229-265
4. Petrilli V, Dostert C, Muruve DA, et al. The inflammasome: A danger sensing complex triggering innate immunity. Curr Opin Immunol 2007;19:615-622
5. Ogura Y, Sutterwala FS, Flavell RA. The inflammasome: First line of the immune response to cell stress. Cell 2006;126:659-662
6. Block TM, Mehta AS, Fimmel CJ, et al. Molecular viral oncology of hepatocellular carcinoma. Oncogene 2003;22:5093-5107
7. Yazdi AS, Drexler SK, Tschopp J. The role of the inflammasome in nonmyeloid cells. J Clin Immunol 2010;30:623-627
8. Peeters PM, Perkins TN, Wouters EF, et al. Silica induces NLRP3 inflammasome activation in human lung epithelial cells. Part Fibre Toxicol 2013;10:3
9. Luedde T, Beraza N, Kotsikoris V, et al. Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell 2007;11:119-132
10. Lockwood DS, Yeadon TM, Clouston AD, et al. Tumor progression in hepatocellular carcinoma: Relationship with tumor stroma and parenchymal disease. J Gastroenterol Hepatol 2003;18: 666-672
11. Zaki MH, Boyd KL, Vogel P, et al. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 2010;32:379-391
12. Allen IC, TeKippe EM, Woodford RM, et al. The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitisassociated cancer. J Exp Med 2010;207:1045-1056
13. Li T, Zhu Y, Qin CY, et al. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma. J Clin Pathol 2012;65:808-814
14. Ganz M, Csak T, Nath B, et al. Lipopolysaccharide induces and activates the Nalp3 inflammasome in the liver. World J Gastroenterol 2011;17:4772-4778
15. Imaeda AB, Watanabe A, Sohail MA, et al. Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. J Clin Invest 2009;119:305-314
16. Martinon F. Detection of immune danger signals by NALP3. J Leukoc Biol 2008;83:507-511
17. Schroder K, Tschopp J. The inflammasomes. Cell 2010;140:821-832
18. Franchi L, Eigenbrod T, Munoz-Planillo R, et al. The inflammasome: A caspase-1-Activation platform that regulates immune responses and disease pathogenesis. Nat Immunol 2009;10:241-247
19. Brenner C, Galluzzi L, Kepp O, et al. Decoding cell death signals in liver inflammation. J Hepatol 2013
20. Anthony K. Immunology: The inflammasome protects?. Nat Rev Cancer 2010;10:383
21. Kanneganti TD, Ozoren N, Body-Malapel M, et al. Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/ Nalp3. Nature 2006;440:233-236
22. Zaki MH, Lamkanfi M, Kanneganti TD. The Nlrp3 inflammasome: Contributions to intestinal homeostasis. Trends Immunol 2011;32:171-179
23. Zaki MH, Vogel P, Body-Malapel M, et al. IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation. J Immunol 2010;185:4912-4920
24. Okamoto M, Liu W, Luo Y, et al. Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1beta. J Biol Chem 2010;285:6477-6488
25. Hu B, Elinav E, Huber S, et al. Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4. Proc Natl Acad Sci USA 2010;107:21635-21640
26. Zitvogel L, Kepp O, Galluzzi L, et al. Inflammasomes in carcinogenesis and anticancer immune responses. Nat Immunol 2012;13:343-351.